New England Deaconess Hospital Corporation

Other

Sandoz Gmbh

Baxter Travenol Laboratories, Inc.

Novartis Ag

Shriners Hospitals for Crippled Children

John M. Daly

George L. Blackburn

Charles T. Van Buren

John E. Kinsella

Novartis Nutrition Inc.

Frank B. Cerra

Frederick Rudolph

Jerome J. Licari

Mitchell T. Gersovitz

Vigen K Babayan

George L Blackburn

Bruce R Bistrian

Edward Anthony Mascioli

John T Daly

Richard Cotter

Jerome J Licari

J Wesley Alexander

John E Kinsella

Charles T Van Buren

Lyle L Moldawer

Mitchell T Gersovitz

Frank B Cerra

John M Daly

The invention provides immunostimulatory compositions comprising an aggregate immunostimulatory amount of

Compositions and methods for the enhancement of host defense mechanisms

The present invention features a transesterification product of a mixture of fatty acids and triglycerides which include dairy fat as a primary component. This composition shows unexpected benefits in nutritional applications either as a food or as an enteral or parenteral supplement. The method of nutritional support using this composition is also disclosed.

Structured lipid containing dairy fat

A new dietary supplement has been developed which yields the benefits of both .omega.3 oils and medium chain triglycerides for lipid nutrition. A structured lipid containing .omega.3 fatty acids and medium chain fatty acids is also disclosed.

Dietary supplement utilizing .omega.-3/medium chain trigylceride mixtures

Chemically synthesized structured triglycerides (lipids) for enteral administration as the lipid calorie source, is subjects undergoing severe metabolic stress.

Triglyceride preparations for the prevention of catabolism

Disclosed is a method of minimizing infection and minimizing the risks of infection in at risk animals and patients. A dietary supplement to accomplish this objective is also disclosed. The method includes the step of administering a diet rich in .omega.3 fatty acids, for example by adding a substantial proportion of fish oils to the diet. The dietary supplement is particularly well suited to patients receiving total parenteral nutrition. A parenteral diet or diet supplement containing a mixture of oils, one rich in .omega.3 fatty acids and the other rich in .omega.6 fatty acids is disclosed.

Parenteral dietary supplement and method of minimizing effects of

A method of treating, and a diet composition for treating patients needing a controlled diet, wherein C.sub.12 fatty acids are the primary fatty acid source. Preferably lauric fats constitute 33-80% of the diet, while LCT's constitute no more than 20%. The lauric fats may be derived from a natural or fractionated kernel oil, selected from a group consisting of babassu oil, coconut oil, cohune oil, palm kernel oil, and tucum oil. A lipid emulsion with diverse additives is described.

Kernel oils and disease treatment

Disclosed is a method of minimizing infection and minimizing the risks of infection in at risk animals and patients. A dietary supplement to accomplish this objective is also disclosed. The method includes the step of administering a diet rich in .omega.3 fatty acids, for example by adding a substantial proportion of fish oils to the diet. The dietary supplement is particularly well suited to patients receiving total parenteral nutrition.

Method of minimizing efects of infection through diet

Medium chain triglyceride containing lipid emulsions for the nutrition of liver diseased or septicemic patients are improved by the inclusion in the emulsions of long chain triglycerides. The emulsions may also contain amino acids in proportions desirable for the nutrition of liver diseased patients, as well as carbohydrates, drugs, vitamins and electrolytes.

Parenteral nutrition with medium and long chain triglycerides

Growing community of inventors

Waban, MA, United States of America

Vigen K Babayan